Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Innovation and Product Development news
(page 21)
19 March 2026
Asahi Kasei awarded Tanahashi Prize for long-term operation of 10 MW alkaline-water electrolysis system
Pilot plants in Namie (since Mar 2020) and Kawasaki (Mar 2024) validated stable alkaline electrolysis, tested 4x0.8 MW multi-modular units for grid response and durability, aiming >100 MW
19 March 2026
Sumitomo Corporation to Deploy Palantir AIP for OCTG Supply Chain DX
AI/data platform to optimize OCTG supply chain—inventory, processing and billing. Europe pilot validated; rollout from FY2026 with phased function and regional expansion.
18 March 2026
Toray to Mass-Produce STF-1000 High-Aspect-Ratio Photosensitive Polyimide
STF-1000 photosensitive polyimide enables 36:1 aspect-ratio patterning in films up to 500 µm, suppressing cracking/delamination for MEMS, semiconductors and scintillators.
18 March 2026
Johnson & Johnson FDA approves ICOTYDE (icotrokinra) for first‑line systemic treatment of plaque psoriasis
First targeted oral IL‑23 receptor peptide approved for moderate‑to‑severe plaque psoriasis in adults and ≥12 (≥40kg). Once‑daily pill; ~70% IGA0/1, 55% PASI90 at Week16; safety like placebo.
18 March 2026
Evonik unveils SPHINOX® Vively sphingolipid
Designer sphingolipid delivers retinol-like rejuvenation with improved tolerance; stimulates elastin, hyaluronic acid and ceramides, reduces IL-1α; biotech-derived, biodegradable; debuts at PCHi 2026
18 March 2026
Refining and Chemical Engineering Group 2025 results
2025: operating revenue RMB700.74B, net profit RMB18.07B; new contracts RMB1,012.48B; first-time special dividend; tech licensing RMB10.13B; overseas front-end wins; front-end/EPC >80% backlog; ESG AA
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
18 March 2026
Clariant unveils Plantasens, Aristoflex SUN and Lucas Meyer blue‑biotech active at PCHi 2026
New emulsifier boosts barrier, hydrates and stabilizes up to 30% oil. Rheology modifier (+0.5%) raised SPF 75% for light textures. Blue‑biotech beats HA; Lysofix soothes skin, fortifies hair.
18 March 2026
Taiwan Bio and Terumo BCT to automate Treg manufacturing on Quantum Flex
Evaluate a 3-in-1 workflow to stabilize and scale Treg production for TRK-001 Phase 2, cut variability and COGS, shorten cycle time, and enable next-gen engineered Treg INDs.
18 March 2026
Boliden invests SEK 4bn in Garpenberg hoist and SEK 1.5bn in Rönnskär SCM plant
SEK 4bn hoist at Garpenberg to keep 4.5 Mt/yr past 2030; SEK 1.5bn Rönnskär demo plant (280 kt/yr SCMentum) 2026–28. SCM emits <5% of cement CO2; exploration continues.
18 March 2026
Asahi Kasei, Nippon Steel and Nippon Steel Trading recycle electrolysis cell titanium scrap into pure titanium
Titanium scrap from chlor-alkali electrolysis cell production is collected, processed and remelted into high-purity titanium with strict contamination control, traceability and recycling targets.
18 March 2026
Avantium reports 2025 full-year results
Phased start-up of the FDCA Flagship Plant progressed despite construction delays; €85M equity and amended financing secured; half the plant operational; full start-up targeted in 2026
18 March 2026
SABIC unveils automotive specialty materials for design, performance and circularity
New PCR-based LNP ELCRIN SLX (30/45% PCR) and KONDUIT WTF2C thermally conductive compounds, plus EXTEM, ULTEM and NORYL grades, boost aesthetics, thermal/EMI performance, weight and recyclability.
18 March 2026
Siemens expands data center ecosystem to accelerate AI deployments
Investment and partnerships add compute-flexibility, grid-scale energy storage and physics-AI modeling to align AI workloads with grid conditions, speed interconnection and scale data center deployments
18 March 2026
Technip Energies acquires minority stake in Verso Energy’s DEZiR eSAF plant in Rouen
Project will use carbon capture to source biogenic CO2 and has FEED underway; plant due ~2030 to produce 80,000 t/yr eSAF, backed by France 2030/EU fund and planned for replication.
17 March 2026
Perimeter Solutions: SOLBERG EVOLUTION 3% SFFF — first Newtonian fluorine‑free foam with FM approval
Mil‑Spec and ICAO Level B certified; UL‑162 approved for fixed sprinkler use; compatible with standard sprinkler hardware and aircraft surfaces; PFAS‑free, biodegradable; validated for ARFF
17 March 2026
Aptar appoints Gael Touya CEO effective Sept 1, 2026; Stephan Tanda to retire end-2026
Gael Touya, a 30-year veteran, led the Pharma unit’s transformation (~82% sales growth) and has global commercial and operational experience. Tanda raised margins, EPS and sustainability.
17 March 2026
Brenntag opens Life Sciences Innovation Center in Shanghai
Expands application expertise for Beauty & Care and Food & Nutrition; offers formulation development, testing, small-batch trials and product concept support for China & Hong Kong clients.
17 March 2026
Siemens and Rittal partner on AI data center power infrastructure
Develops scalable, standardized IEC/OCP power distribution for AI data centers - including a white-space 'sidecar' power rack - to handle rising rack densities, speed deployment, and boost efficiency.
17 March 2026
Siemens and Rittal partner on data center power infrastructure
Create standardized, sustainable power distribution for AI data centers: in-rack power units, low-voltage modular/container systems, cooling & safety solutions; pilots underway.
17 March 2026
Kemira obtains PMRA approval in Canada for KemConnect DEX
Chlorine-free performic-acid wastewater disinfection; used in Paris 2024 wastewater works. Combines on-site generation, real-time monitoring and dosing algorithm. Canada rollout pending approvals
17 March 2026
BASF Agricultural Solutions invests €17M to expand Saskatoon canola breeding centre
Construction 2026–2027 adds automation, genomic-selection pipelines and a research glasshouse to boost breeding throughput, speed genetic gain and deliver higher-yield, disease-resistant hybrids
17 March 2026
Symrise Launches Care & Wellness Division
The new division integrates cosmetic ingredients, health actives, and biotics to meet demand for holistic care solutions, enhancing innovation and market readiness.
17 March 2026
Clariant Enhances Agricultural Solutions at CAC 2026
Clariant introduces Dispersogen PSL 100 and Tonnegel 50 for improved formulation stability and rheology in agriculture, supporting biological crop protection and operational efficiency.
16 March 2026
Roche Unveils NVIDIA-Powered AI Factory for Therapeutics and Diagnostics
Roche expands its AI infrastructure with 2,176 NVIDIA GPUs, enhancing drug development, diagnostics, and manufacturing through advanced computing and AI integration.
16 March 2026
Aptar's Nasal Delivery System in Phase II Study for SPONTAN® Spray
Aptar's nasal system aids LTR Pharma's SPONTAN® Phase II study, focusing on safety, tolerability, and pharmacokinetics for erectile dysfunction treatment.
16 March 2026
Lilly's EBGLYSS Achieves Positive Phase 3 Results in Pediatric Atopic Dermatitis
EBGLYSS shows significant skin improvement and itch relief in children with moderate-to-severe atopic dermatitis, meeting primary and secondary endpoints in Phase 3 ADorable-1 trial.
16 March 2026
Merck Presents New Cardio-Pulmonary Data at ACC.26
Merck shares positive Phase 3 and Phase 2 trial results for enlicitide and WINREVAIR™ at ACC.26, highlighting advancements in hypercholesterolemia and CpcPH-HFpEF research.
16 March 2026
LANXESS Showcases Cosmetics and Personal Care Portfolio at in-cosmetics Global
LANXESS highlights preservation solutions, sustainable ingredients, and global production capabilities for cosmetics and personal care at the Paris trade fair.
16 March 2026
Neste opens largest facility for upgrading liquefied waste plastic
The new facility processes 150,000 tons of waste plastic annually, advancing chemical recycling and reducing fossil resource use and emissions.
13 March 2026
Johnson & Johnson Reports Positive Phase 1 Results for Erda-iDRS in Bladder Cancer
Erda-iDRS shows safety and efficacy in Phase 1 for intermediate-risk bladder cancer, with high complete response rates and ongoing Phase 2 and 3 studies.
← Previous
Next →
